TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-09-12
Last Posted Date
2021-11-15
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
103
Registration Number
NCT00375219
Locations
🇺🇸

Teva Investigational Site 003, Los Angeles, California, United States

🇫🇷

Teva Investigational Site 029, Bordeaux, France

🇫🇷

Teva Investigational Site 021, Le Chesnay Cedex, France

and more 29 locations

A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

First Posted Date
2006-07-06
Last Posted Date
2011-04-08
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
306
Registration Number
NCT00349193

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Completed
Conditions
Interventions
First Posted Date
2006-06-13
Last Posted Date
2013-10-30
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
1230
Registration Number
NCT00336557
Locations
🇺🇸

Neuro-Pain Medical Center, Fresno, California, United States

🇺🇸

Fullerton Neurology and Headache Center, Fullerton, California, United States

🇺🇸

East Bay Physicians Medical Group, Berkley, California, United States

and more 46 locations

Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

Phase 3
Completed
Conditions
Interventions
First Posted Date
2006-03-30
Last Posted Date
2022-04-01
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
95
Registration Number
NCT00308685
Locations
🇺🇸

Allergy & Asthma Specialist Medical Group, Huntington Beach, California, United States

🇺🇸

Little Rock Allergy and Asthma, Little Rock, Arkansas, United States

🇺🇸

Allergy & Asthma Associates of Santa Clara Valley Research Center, San Jose, California, United States

and more 9 locations

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-11-21
Last Posted Date
2012-01-12
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
1174
Registration Number
NCT00256204

Non-invasive Measures of Distal Lung Disease in Asthmatics

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-11-08
Last Posted Date
2021-12-02
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
34
Registration Number
NCT00250341
Locations
🇺🇸

UCLA, Los Angeles, California, United States

Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

Phase 2
Completed
Conditions
First Posted Date
2005-10-05
Last Posted Date
2021-11-12
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
15
Registration Number
NCT00232999
Locations
🇨🇦

Department of Medicine, McMaster University, Hamilton, Ontario, Canada

🇨🇦

Centre de cardiology et de pneumologie de l'Universite Laval, Sainte-Foy (Quebec City), Quebec, Canada

🇨🇦

University of Saskatchewan, Saskatoon, Saskatchewan, Canada

© Copyright 2024. All Rights Reserved by MedPath